Necchi, Andrea
Lo Vullo, Salvatore
Mariani, Luigi
Raggi, Daniele
Giannatempo, Patrizia
Calareso, Giuseppina
Togliardi, Elena
Crippa, Flavio
Di Genova, Nicola
Perrone, Federica
Colecchia, Maurizio
Paolini, Biagio
Pelosi, Giuseppe
Nicolai, Nicola
Procopio, Giuseppe
Salvioni, Roberto
De Braud, Filippo G.
Funding for this research was provided by:
Millennium Takeda
Fondazione IRCCS Istituto Nazionale dei Tumori
Article History
Received: 13 January 2016
Accepted: 1 February 2016
First Online: 12 February 2016
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: The study was partially supported by Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.Next generation sequencing analyses were supported in part by funds obtained through an Italian law that allows taxpayers to allocate 0.5 % share of their income tax contribution to a research Institution of their choice.